EP1156819A4 - Methodes et compositions utilisees pour la modulation de la fertilite - Google Patents

Methodes et compositions utilisees pour la modulation de la fertilite

Info

Publication number: EP1156819A4
Authority: EP; European Patent Office
Prior art keywords: compositions; methods; modulating fertility; fertility; modulating
Prior art date: 1999-02-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00914482A

Other languages

German (de)

English (en)

Other versions

EP1156819A1 (fr

Inventor

John Herr

Arabinda Mandal

Michael Wolkowicz

Kenneth Klotz

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

UVA Licensing and Ventures Group

University of Virginia UVA

Original Assignee

University of Virginia UVA

University of Virginia Patent Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-01

Filing date

2000-02-01

Publication date

2003-01-02

2000-02-01 Application filed by University of Virginia UVA, University of Virginia Patent Foundation filed Critical University of Virginia UVA

2001-11-28 Publication of EP1156819A1 publication Critical patent/EP1156819A1/fr

2003-01-02 Publication of EP1156819A4 publication Critical patent/EP1156819A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Reproductive Health (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

EP00914482A 1999-02-01 2000-02-01 Methodes et compositions utilisees pour la modulation de la fertilite Withdrawn EP1156819A4 (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US11803099P	1999-02-01	1999-02-01
US118030P		1999-02-01
US11899599P	1999-02-08	1999-02-08
US118995P		1999-02-08
PCT/US2000/002675 WO2000044395A1 (fr)	1999-02-01	2000-02-01	Methodes et compositions utilisees pour la modulation de la fertilite

Publications (2)

Publication Number	Publication Date
EP1156819A1 EP1156819A1 (fr)	2001-11-28
EP1156819A4 true EP1156819A4 (fr)	2003-01-02

Family

ID=26815894

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00914482A Withdrawn EP1156819A4 (fr)	1999-02-01	2000-02-01	Methodes et compositions utilisees pour la modulation de la fertilite

Country Status (5)

Country	Link
EP (1)	EP1156819A4 (fr)
JP (1)	JP2003525021A (fr)
AU (1)	AU772403B2 (fr)
CA (1)	CA2361271A1 (fr)
WO (1)	WO2000044395A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002307438A1 (en) *	2001-04-20	2002-11-05	Ludwig Institute For Cancer Research	Cancer-testis antigens
CL2010000261A1 (es)	2010-03-23	2010-06-11	Laboratorios Andromaco S A 8 5%	Peptidos derivados del veneno de latrodectus mirabilis, secuencias que lo codifican, procedimiento de produccion de dichos peptidos, composiciones farmaceuticas que los comprenden, y uso anticonceptivos de las mismas.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2001054477A2 (fr) *	2000-01-25	2001-08-02	Hyseq, Inc.	Nouveaux acides nucleiques et polypeptides
EP1130094A2 (fr) *	1999-07-08	2001-09-05	Helix Research Institute	Amorces pour la synthèse de cADN de pleine longueur et leur utilisation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4795634A (en) *	1986-03-14	1989-01-03	Aphton Corporation	Method for contraception by immunization against the zona pellucida
US5346990A (en) *	1987-04-08	1994-09-13	Cytogam, Inc.	Sex-associated membrane proteins and methods for increasing the probability that offspring will be of a desired sex
US5641487A (en) *	1989-06-12	1997-06-24	The Government Of The United States Of America As Represented By The Secretary Department Of Health And Human Services	Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
US5525592A (en) *	1993-11-30	1996-06-11	Eric R. Lacy	Alkaline gland fluid proteins and methods of enhancing and inhibiting sperm motility
US5637300A (en) *	1994-08-03	1997-06-10	Dunbar; Bonnie S.	Contraceptive vaccine comprising a glycosylated 55 kD zona pellucida protein immunogen and method of use of the same in contraception

2000
- 2000-02-01 WO PCT/US2000/002675 patent/WO2000044395A1/fr not_active Ceased
- 2000-02-01 EP EP00914482A patent/EP1156819A4/fr not_active Withdrawn
- 2000-02-01 JP JP2000595697A patent/JP2003525021A/ja active Pending
- 2000-02-01 AU AU35868/00A patent/AU772403B2/en not_active Ceased
- 2000-02-01 CA CA002361271A patent/CA2361271A1/fr not_active Abandoned

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1130094A2 (fr) *	1999-07-08	2001-09-05	Helix Research Institute	Amorces pour la synthèse de cADN de pleine longueur et leur utilisation
WO2001054477A2 (fr) *	2000-01-25	2001-08-02	Hyseq, Inc.	Nouveaux acides nucleiques et polypeptides

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EMBL; 17 August 1998 (1998-08-17), "ov24d10.x1 Soares testis NHT Homo sapiens cDNA clone IMAGE:1638259", XP002218762, Database accession no. AI081873 *
DATABASE EMBL [online] EMBL; 23 September 1998 (1998-09-23), MANDAL: "Homo sapiens fibrousheathin I mRNA", XP002218767, Database accession no. AF087003 *
DATABASE EMBL [online] EMBL; 25 September 1998 (1998-09-25), "qe03f10.x1 Soares testis NHT homo sapiens cDNA clone IMAGE:1737931", XP002218763, Database accession no. AI138771 *
DATABASE EMBL [online] EMBL; 8 October 1998 (1998-10-08), VIJAYARAGHAVAN: "Bos taurus protein kinase A binding protein AKAP110 mRNA", XP002218766, Database accession no. AF093407 *
DATABASE EMBL [online] EMBL; 8 October 1998 (1998-10-08), VIJAYARAGHAVAN: "Homo sapiens protein kinase A binding protein AKAP110 mRNA", XP002218764, Database accession no. AF093408 *
DATABASE EMBL [online] EMBL; 8 October 1998 (1998-10-08), VIJAYARAGHAVAN: "Mus musculus protein kinase A binding protein AKAP110 mRNA", XP002218765, Database accession no. AF093406 *
LEFEVRE A (REPRINT) ET AL: "SOB1 -g, a human gene coding for a sperm protein with potential oocyte binding activity", HUMAN REPRODUCTION, (JUN 1997) VOL. 12, SUPP. [1], PP. P24-P24. PUBLISHER: OXFORD UNIV PRESS, GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP. ISSN: 0268-1161., INSERM, U355, F-92140 CLAMART, FRANCE, XP001117984 *
LEFEVRE A ET AL: "Cloning and characterization of SOB1, a new testis-specific cDNA encoding a human sperm protein probably involved in oocyte recognition.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 259, no. 1, 27 May 1999 (1999-05-27), pages 60 - 66, XP002218761, ISSN: 0006-291X *
MANDAL A ET AL: "FSP95, A TESTIS-SPECIFIC 95-KILODALTON FIBROUS SHEATH ANTIGEN THAT UNDERGOES TYROSINE PHOSPHORYLATION IN CAPACITATED HUMAN SPERMATOZOA", BIOLOGY OF REPRODUCTION, SOCIETY FOR THE STUDY OF REPRODUCTION, CHAMPAIGN, IL, US, vol. 61, no. 5, AF087003, 1999, pages 1184 - 1197, XP001029106, ISSN: 0006-3363 *
MANDAL A ET AL: "TWO NOVEL HUMAN SPERM FIBROUS SHEATH PROTEINS WHICH UNDERGO PHOSPHORYLATION DURING CAPACITATION", MOLECULAR BIOLOGY OF THE CELL, BETHESDA, MD, US, vol. 9, no. SUPPL, November 1998 (1998-11-01), pages 66A, XP001029742, ISSN: 1059-1524 *
See also references of WO0044395A1 *
VIJAYARAGHAVAN S ET AL: "ISOLATION AND MOLECULAR CHARACTERIZATION OF AKAP110, A NOVEL, SPERM-SPECIFIC PROTEIN KINASE A-ANCHORING PROTEIN", MOLECULAR ENDOCRINOLOGY, BALTIMORE, MD, US, vol. 13, no. 5, May 1999 (1999-05-01), pages 705 - 717, XP001029110, ISSN: 0888-8809 *

Also Published As

Publication number	Publication date
AU772403B2 (en)	2004-04-29
CA2361271A1 (fr)	2000-08-03
JP2003525021A (ja)	2003-08-26
EP1156819A1 (fr)	2001-11-28
AU3586800A (en)	2000-08-18
WO2000044395A1 (fr)	2000-08-03
WO2000044395A9 (fr)	2002-05-02

Publication	Publication Date	Title
IL146872A0 (en)	2002-08-14	Methods and compositions for modulating cell proliferation and cell death
PL350797A1 (en)	2003-02-10	Compositions for improving fertility
GB2348808B (en)	2003-03-19	Methods and compositions for desensitisation
HUP0201436A3 (en)	2003-04-28	Methods and compositions for treating solid tumors
AUPQ127399A0 (en)	1999-07-22	Compositions and methods for treating or preventing osteoporosis
PL347497A1 (en)	2002-04-08	Compositions and methods for preparing dispersions and methods for using the dispersions
EP1056456A4 (fr)	2006-10-25	Compositions et procedes d'utilisation du r-lansoprazole
IL145891A0 (en)	2002-07-25	Methods and compositions for modulating an immune response
AU5565099A (en)	2000-05-08	Pharmaceutical compositions and methods for use
EP1056457A4 (fr)	2006-10-25	Compositions de s-lansoprazole et procedes d'utilisation
HUP0103473A3 (en)	2003-01-28	Phosphoglycolipid and methods for its use
AU7816000A (en)	2001-04-23	Pediculocidal and veterinary compositions
EP1073333A4 (fr)	2005-06-15	Compositions a base de s-rabeprazole et procedes
AUPO982097A0 (en)	1997-11-06	Methods and compositions for use therein
GB9922135D0 (en)	1999-11-17	Compositions and uses
IL140574A0 (en)	2002-02-10	Methods and compositions for modulating spermatogenesis
EP1156819A4 (fr)	2003-01-02	Methodes et compositions utilisees pour la modulation de la fertilite
GB0318107D0 (en)	2003-09-03	›-Secretase enzyme compositions and methods
AU2880699A (en)	1999-10-25	Pharmaceutical compositions and methods for use
HUP0101602A3 (en)	2004-10-28	Fertility improving composition and application thereof
AU5243899A (en)	2000-02-21	Methods and compositions for using moclobemide
EP1073332A4 (fr)	2005-06-15	Compositions a base de r-rabeprazole et procedes
HUP0203807A3 (en)	2004-10-28	Compositions and methods for halogenation reactions
AU5931300A (en)	2001-01-30	Ringene compositions and methods for use thereof
AU6627800A (en)	2001-03-13	Methods and compositions for modulating somatolactogenic functions

Legal Events

Date	Code	Title	Description
2001-10-12	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2001-11-28	17P	Request for examination filed	Effective date: 20010813
2001-11-28	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2001-11-28	AX	Request for extension of the european patent	Free format text: AL;LT;LV;MK;RO;SI
2003-01-02	A4	Supplementary search report drawn up and despatched	Effective date: 20021115
2003-01-02	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2006-01-27	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2006-03-15	18D	Application deemed to be withdrawn	Effective date: 20050901